LPTI Stock Overview
Develops, manufactures, markets, and sells high resolution ultrasound imaging systems primarily in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Longport, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -50.00% |
| 5 Year Change | -96.00% |
| Change since IPO | -99.99% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| LPTI | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 0% | 2.4% | 0.5% |
| 1Y | n/a | 15.6% | 30.7% |
Return vs Industry: Insufficient data to determine how LPTI performed against the US Biotechs industry.
Return vs Market: Insufficient data to determine how LPTI performed against the US Market.
Price Volatility
| LPTI volatility | |
|---|---|
| LPTI Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 9.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: LPTI's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine LPTI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | n/a | Michael Boyd | www.longportinc.com |
Longport, Inc. develops, manufactures, markets, and sells high resolution ultrasound imaging systems primarily in the United States. It offers EPISCAN I-200, a high frequency ultrasound imaging system that utilizes ultrasound at frequencies between 20 and 50MHz to image the skin and underlying soft tissue. The company’s products are used in wound assessment, wound prevention, clinical dermatology, and aesthetics/plastics, as well as in various other applications, including burn assessment, superficial musculoskeletal imaging, and veterinary applications.
Longport, Inc. Fundamentals Summary
| LPTI fundamental statistics | |
|---|---|
| Market cap | US$2.31k |
| Earnings (TTM) | -US$1.31m |
| Revenue (TTM) | US$1.19m |
0.0x
P/S Ratio0.0x
P/E RatioIs LPTI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LPTI income statement (TTM) | |
|---|---|
| Revenue | US$1.19m |
| Cost of Revenue | US$558.65k |
| Gross Profit | US$627.85k |
| Other Expenses | US$1.94m |
| Earnings | -US$1.31m |
Last Reported Earnings
Sep 30, 2005
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did LPTI perform over the long term?
See historical performance and comparison